Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
CASPIAN investigators
- Hospital Universitario 12 de Octubre
- BHI of Omsk Region Clinical Oncology Dispensary
- Cancer and Hematology Centers of Western Michigan
- Asklepios Lung Clinic
- Okayama University
- Odessa National Medical University
- Omsk Regional Cancer Center
- Karl Landsteiner Institute of Lung Research and Pulmonary Oncology
- Istanbul University - Cerrahpaşa
- Samsung Changwon Hospital
- Kyiv City Clinical Oncological Centre
- Russian Ministry of Health
- AO Ospedali Riuniti PO Vincenzo Cervello
- Charles University
- Zaporizhia Medical Academy of Post-Gradate Education Ministry of Health of Ukraine
- Tuberculosis and Lung Disease Hospital
- Semmelweis University
- University Hospital St. Marina
- AstraZeneca
- University of California at Los Angeles
- Unknown
研究成果: 期刊稿件 › 文章 › 同行評審
1706
引文
斯高帕斯（Scopus）